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Introduction: The use of antibiotics is very high in the departments of Emergency and Trauma Surgery above all
in the treatment of the intra-abdominal infections, to decrease morbidity and mortality rates; often the antimicrobial
drugs are prescribed without a rationale and they are second-line antibiotics; this clinical practice increases costs
without decreasing mortality.
Aim of our study is to report the results in the application to the clinical practice of the World Society Emergency
Surgeons (WSES) guidelines for the management of intra-abdominal infections, at the department of Emergency and
Trauma Surgery of the University Hospital of Parma (Italy) in 2012.
Methods: A retrospective observational analysis was carried out about patients admitted in the department of
Emergency and Trauma Surgery of Parma (Italy), between January 2011 and December 2012. The data are
expressed as percentages (%) and means (± SD). The results of the compared groups were analyzed using the
Pearson’s Chi-Square and Fisher’s tests. For means involving continuous numerical data, the independent sample
T test and the Mann–Whitney U-test were used for normally and abnormally distributed data, respectively (the
data had been previously tested for normality using the Kolmogorov-Smirnov test). A p-value < 0.05 was considered
statistically significant.
Results: Between January 2011 and December 2012, 2121 (968 in 2011 and 1153 in 2012) patients were admitted in
the department of Emergency and Trauma Surgery (Italy) of Parma University Hospital with a diagnosis of acute IAI.
Morbidity in 2012 was 10,2% compared to 22.7% in 2011 and mortality in 2012 was 1,1% compared to 3,2% in 2011 (p < 0,05).
Costs for antibiotics in 2012 was 51392 euro, with a reduction of 31% compared to 2011.
Conclusions: This study demonstrates that an inexpensive and easily application of guidelines based on medicine
evidence in the use of antibiotics can lead to a significative reduction of hospital costs with outcomes improvement.
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Antibiotics are the essential drugs that we have to fight
and prevent bacterial infectious diseases. Improper and
excessive use of antibiotics is the major worldwide
problem because it has an important economic impact
on increasing healthcare costs, caused by the selection
of multi-drug resistant bacteria, resulting in a longer
hospital stay and an higher mortality [1]. For the World* Correspondence: desimoneB@hotmail.it
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unless otherwise stated.Health Organization (WHO), the rational use of drugs
requires that patients receive medications appropriate to
their clinical needs, in doses that meet their own individ-
ual requirements, for an adequate period of time and at
the lowest cost, to them and their community [2]; be-
cause each antibiotic has different unit dose of daily
administration, a specific standardized method to evalu-
ate the in-hospital antibiotic use was suggested and
periodically update by WHO, the ATC/DDD index
(Anatomical Therapeutic Chemical/Defined Daily Dose):
it is considered the universal parameter to calculate the
antibiotic use intensity [3]. Furthermore, the use oftral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
De Simone et al. World Journal of Emergency Surgery  (2015) 10:18 Page 2 of 6antibiotic prophylaxis, according to standardized proto-
cols, has been shown to prevent post-surgical wound in-
fections, which are the primary cause of morbidity and
mortality in patients undergoing surgery.
The use of antibiotics is very high in the departments
of Emergency and Trauma Surgery, above all in the
treatment of the intra-abdominal infections (IAIs) to
decrease morbidity and mortality rates. Often the
antimicrobial drugs are prescribed without a rationale
and they are second-line antibiotics; this clinical practice
increases costs without decreasing mortality [4]. Sartelli
et al., during the 1st Congress of the World Society
of Emergency Surgeons (WSES), discussed in a multi-
disciplinary approach these problems, approving evi-
dence based recommendations for the management of
IAIs [1]. According to the WSES guidelines, the initial
antibiotic therapy for IAIs is always empiric because the
patient is often critically ill and microbiological data
(culture and susceptibility results) usually take at least
48 hours to become fully available [1]. IAIs are classified
as uncomplicated and complicated. The uncomplicated
infections involve a single organ and do not spread to
the peritoneum (antimicrobial therapy is indicated as
first line approach); the complicated IAIs proceed
beyond a single organ, causing localized or diffuse
peritonitis and need for surgical and antimicrobial
therapy.
IAIs are divided in 3 sub-groups: 1. community ac-
quired extrabiliary infections: gastroduodenal perfora-
tions, small bowel perforations, acute appendicitis,
acute diverticulitis, large bowel perforations; 2. com-
munity acquired biliary infections:acute cholecystitis,
cholangitis; 3. hospital acquired infections: postopera-
tive and non-postoperative peritonitis. Once the diag-
nosis of intra-abdominal infection is suspected, it is
necessary to begin, as soon as possible, the empiric
antimicrobial therapy, even if routine use of antimicro-
bial therapy is not appropriate for all patients with
intra-abdominal infections. Source control should be
obtained as early as possible after the diagnosis of
postoperative intra-abdominal peritonitis has been con-
firmed [1].
The principles of empiric antibiotic treatment should
be defined according to the most frequently isolated
germs, always taking into consideration the local trend
of antibiotic resistance. The choice of the antimicrobial
regimen depends on the source of intra-abdominal in-
fection, the risk factors for specific microorganisms, the
resistance patterns and the clinical patient’s condition.
In uncomplicated IAIs, when the focus of infection is
treated effectively by surgical excision of the involved
tissue, the administration of antibiotics is unnecessary
beyond prophylaxis. In complicated IAIs, antimicrobial
therapy is mandatory. Hospital acquired infections arecommonly caused by larger and more resistant flora,
and for these infections, complex multi-drug regimens
are always recommended [1].
We report the results in the application to the clinical
practice of the WSES guidelines for the management of
intra-abdominal infections at the Department of Emer-
gency and Trauma Surgery of Parma University Hospital
(Italy) in 2012.Materials and methods
A retrospective observational analysis was carried out
about patients with IAIs admitted to the Department
of Emergency and Trauma Surgery of Parma University
Hospital, between January 2011 and December 2012
The following parameters were collected: patients
demographics, diagnosis, surgical procedures performed,
antibiotic treatment, length of hospital stay (day) and
outcomes. In 2011 and 2012, the same antibiotic drugs
were available in our hospital, at the same price.
In 2011, no guidelines were used, whereas in 2012
WSES IAIs guidelines were utilized. (Figure 1) Com-
munity acquired extra-biliary IAIs (gastro-duodenal
perforations, small bowel perforations, acute appendi-
citis, acute diverticulitis, large bowel perforations)
were treated with Ampicillin/Sulbactam or Ciprofloxacin
(in patients with allergic reaction to Penicillin) +/−
Metronidazole.
Community acquired biliary IAIs (cholecystitis, cholangitis)
were treated with Ampicillin/Sulbactam or Ciprofloxacin,
if allergic reaction to Penicillin, +/− Metronidazole, as
first line therapy, if an ESBL or MDR pathogens were
suspected.
Hospital acquired IAIs needed for a large spectrum ther-
apy (high risk of ESBL or MDR pathogens involved) with
Piperacillin/Tazobactam or Meropenem +/−Fluconazole +/−
Tigecycline. Critically ill patients were often hospital-
ized in ICU.
All antibiotic treatments started with an i.v. administra-
tion followed by oral switch when appropriate (normal
infection signs, normal infection laboratory parameters
and resumption of oral feeding).
The data are expressed as percentages (%) and means
(± SD). The results of the compared groups were ana-
lyzed using the Pearson’s Chi-Square and Fisher’s Exact
tests, as appropriate, for proportions involving discrete
data. The Fisher’s Exact test was used when the data
were unequally distributed among the cells of the table,
when the expected frequency of any cell was less than 5,
or when the total number (N) was less than 50.
For means involving continuous numerical data,
the independent sample T test and the Mann–Whitney
U-test were used for normally and abnormally distributed
data, respectively (the data had been previously tested
Figure 1 WSES IAIs guidelines.
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p-value < 0.05 was considered statistically significant.Results
Between January 2011 and December 2012, 2121 (968 in
2011 and 1153 in 2012) patients were admitted in the
Department of Emergency and Trauma Surgery of
Parma University Hospital with a diagnosis of acute IAI.
The mean age was 58,8 years (SD ± 9,1) in 2011 and 59,1
in 2012 (SD ± 8.9); (p = n.s.). Male/ female ratio was 1,04
in 2012 and 1,02 in 2011 (p = n.s.). Complicated IAIs
were 41,1% in 2012 and 38,7% in 2011. (p = n.s.).
Empirical treatment was performed in 91,8% of pa-
tients in 2012 and in 95,3% of patients in 2011 (p = n.s.).In the Figure 2 patients were divided according to ad-
mission diagnosis: the majority of patients were affected
by acute cholecystitis, followed by acute appendicitis
and complicated abdominal hernias, including incisional
hernias, without any statistical difference in distribution
between 2011 and 2012. (p = n.s.). Surgical procedures,
performed as source control on these patients, are shown
in Figure 3: again there was not any statistical difference
in distribution between 2011 and 2012. (p = n.s.).
All patients with IAIs were treated with antibiotics
according to WSES guidelines.
The administrated antibiotic treatments is shown in
Figure 4. Between 2011 and 2012 there was a statistical
significant difference for 5 antibiotic regimens: Ampicillin/
Sulbactam, Ciprofloxacin plus Metronidazole, Meropenem,
Figure 2 IAI patients divided according to admission diagnosis in 2011 and in 2012.
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Tazobactam. The oral switch was performed in 540/ 968
(55,7%) patients in 2011 and in 691/1153 (59,9%) in 2012.
(p = n.s.).
The mean length of intravenous therapy was 4.9 days
(range 21–1) (DS 3,67) and the mean lenght of oral therapy
was 3.23 days (range 13–3) (DS 3,18) in 2012, whereas the
mean length of intravenous therapy was 5.4 days (range
33–2) (DS 4,22) and the mean lenght of oral therapy wasFigure 3 Surgical procedures performed as source control on IAI pati4,59 days (range 18–4) (DS 2,25); (p = n.s.) in 2011. Mean
lenght of hospital stay was 7.5 days (range 43–1) (DS 6,08)
in 2012 and 8,9 days (range 49–1) (DS 5,36) in 2011 (p= n.s.).
In-hospital mortality rate was 1.10% in 2012 vs 3.2% in
2011 (p < 0.05.) and morbidity was 10,2% in 2012 vs
22,7% in 2011 (p < 0.05). Costs for antibiotics in 2012
was 51392 euro compared to 75327 euro in 2011 (31,7%
reduction). More common bacteria isolates were com-
parable between 2011 and 2012.ents in 2011 and in 2012.
Figure 4 The administrated antibiotic treatments in 2011 and in 2012.
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It’s worldwide accepted that a remarkable amount of
antibiotics used in hospitalized patients is excessive or
inappropriate; this irrational use of antibiotics leads to the
emergence of drug resistant bacteria, associated with an
higher rates of death, illness and prolonged hospital stay,
with a considerable increasing of the healthcare costs.
Besides the research involved with the development of
new antibiotics has no progressed in parallel with the
increasing rates of resistance, leaving clinicians with fewer
options, often more expensive, for the treatment of some
resistant infections.
In the recent literature, several studies argue on the
necessity of the diffusion of valid guidelines, based on
clinical evidence and on the bacterial resistance epidemi-
ology, to rationalize the use of antibiotics [2-6]. Many
authors highlight on the importance of the application
of validated guidelines in clinical practice and of the
surgical prophylaxis protocols, associated with adequate
education programs for physicians and surgeons on the
“diligent” prescription and administration of antibiotics,
in reducing healthcare costs with considerable benefits
in terms of cost-effectiveness [7-11].
In the present study, the application of WSES guide-
lines for the management of intra-abdominal infections
was highly effective in reducing the number of unneces-
sary second-line antibiotics prescriptions and costs; it
led to a 31% reduction of costs for antimicrobial drugs,keeping low morbidity and low mortality rates. The source
control associated with an adequate antimicrobial therapy
are efficacy to decrease morbidity and mortality rates.
This study demonstrates that an inexpensive and easily
application of guidelines based on medicine evidence in
the use of antibiotics can lead to a significant reduction
of hospital costs. There is an urgent need to develop
education programs, to spread valid guidelines in the use
of antimicrobial agents, to limit the emergence of bacterial
resistance, responsible of the increasing in the incidence
of “difficult” infectious diseases and deaths, and to reduce
costs resulting from this global problem [10-12].Competing interests
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